신규 트리테르페노이드 및 이의 용도
    1.
    发明公开
    신규 트리테르페노이드 및 이의 용도 有权
    新颖的TRITERPENOID及其使用

    公开(公告)号:KR1020120028043A

    公开(公告)日:2012-03-22

    申请号:KR1020100090002

    申请日:2010-09-14

    Abstract: PURPOSE: Triterpenoid extracted from steamed acanthopanax koreanum leaves, a producing method thereof, and a use thereof are provided to offer an excellent production inhibition effect of tumor necrosis factor-alpha, interleukin-12, and interleukin-6 to users. CONSTITUTION: Triterpenoid or its salt extracted from steamed acanthopanax koreanum leaves has a structure marked with chemical formula 1. The triterpenoid is extracted from the following steps: steaming the acanthopanax koreanum, and extracting the steamed acanthopanax koreanum leaves with alcohol; suspending the obtained extract, and separating alkyl acetate fractions; and processing the alkyl acetate fractions with the column chromatography.

    Abstract translation: 目的:提供蒸气刺五加叶提取的三萜类化合物及其制备方法及其用途,为使用者提供了肿瘤坏死因子-α,白细胞介素-12和白细胞介素-6的良好抑制作用。 构成:从荆棘山楂叶提取的三萜类化合物或其盐具有化学式1的结构。三萜类化合物从以下步骤中提取:蒸煮刺五加,用酒精提取蒸气刺五加叶; 悬浮所得提取物,分离出乙酸甲酯馏分; 并用柱色谱处理乙酸烷基酯馏分。

    트리테르페노이드의 자가 면역 질환의 예방 및 치료 용도
    2.
    发明授权
    트리테르페노이드의 자가 면역 질환의 예방 및 치료 용도 有权
    用于预防和治疗自身免疫疾病的TRITERPENOID

    公开(公告)号:KR101113202B1

    公开(公告)日:2012-02-16

    申请号:KR1020100088573

    申请日:2010-09-09

    CPC classification number: A61K31/56 A23L33/10 A61K8/63 A61K31/19 Y10S424/81

    Abstract: PURPOSE: A composition of triterpenoid for preventing and treating autoimmune diseases is provided to suppress IL-12, IL-6, and TNF-alpha. CONSTITUTION: A pharmaceutical composition for preventing and treating autoimmune diseases contains triterpenoid of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. In chemical formula 1, R1 is CHO or CH_3; and R2 is O or CH_2. The composition additionally contains a carrier, excipient, disintegrant, sweetener, coating agent, lubricant, flavoring agent, anti-oxidant, buffer solution, diluents, dispersion agent, surfactant, or binder. The pharmaceutical composition is used in the form of a granule, powder, coating tablet, capsule, suppository, syrup, juice, suspension, emulsion, or liquid.

    Abstract translation: 目的:提供用于预防和治疗自身免疫性疾病的三萜类化合物,以抑制IL-12,IL-6和TNF-α。 构成:用于预防和治疗自身免疫疾病的药物组合物含有化学式1的三萜化合物或其药学上可接受的盐作为活性成分。 在化学式1中,R1是CHO或CH_3; R2是O或CH_2。 该组合物还含有载体,赋形剂,崩解剂,甜味剂,包衣剂,润滑剂,调味剂,抗氧化剂,缓冲溶液,稀释剂,分散剂,表面活性剂或粘合剂。 药物组合物以颗粒,粉末,包衣片,胶囊,栓剂,糖浆,果汁,悬浮液,乳液或液体的形式使用。

Patent Agency Ranking